Lars Vilén

459 total citations
18 papers, 270 citations indexed

About

Lars Vilén is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Genetics. According to data from OpenAlex, Lars Vilén has authored 18 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 7 papers in Hematology and 6 papers in Genetics. Recurrent topics in Lars Vilén's work include Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Lars Vilén is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Lars Vilén collaborates with scholars based in Sweden, Norway and United Kingdom. Lars Vilén's co-authors include Jack Kutti, Hans Wadenvik, Hans Wedel, Börje Ridell, Per Lundborg, Björn Andréasson, Peter Johansson, Soodabeh Safai‐Kutti, Jan Westin and Jan Carneskog and has published in prestigious journals such as Blood, Stem Cells and British Journal of Haematology.

In The Last Decade

Lars Vilén

18 papers receiving 247 citations

Peers

Countries citing papers authored by Lars Vilén

Since Specialization

Citations

This map shows the geographic impact of Lars Vilén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Vilén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Vilén more than expected).

Fields of papers citing papers by Lars Vilén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Vilén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Vilén. The network helps show where Lars Vilén may publish in the future.

Co-authorship network of co-authors of Lars Vilén

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Vilén. A scholar is included among the top collaborators of Lars Vilén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Vilén. Lars Vilén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Trends in the incidence of chronic Philadelphia chromosome negative (Ph‐) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983–99 2004 ·Journal of Internal Medicine ·Peter Johansson, Jack Kutti, Björn Andréasson, Soodabeh Safai‐Kutti, Lars Vilén, Hans Wedel, Börje Ridell	48
2	On the diagnosis of polycythaemia vera as assessed in the health and medical care in the Västra Götaland region, Sweden 2002 ·Journal of Internal Medicine ·Peter Johansson, Björn Andréasson, Soodabeh Safai‐Kutti, (unknown), Lars Vilén, (unknown), Jack Kutti	7
3	Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase – a report from the Swedish CML Group 2002 ·British Journal of Haematology ·Ulla Axdorph, Leif Stenke, Gunnar Grimfors, Jan Carneskog, Jan Erik Hansen, Olle Linder, Per Ljungman, Eva Löfvenberg, Claes Malm, Bengt Simonsson, Ingemar Turesson, Lars Vilén, A.‐M. Udén, Magnus Björkholm, (unknown)	16
4	Incidence of chronic myeloproliferative disorders in the city of Göteborg, Sweden 1983–1992 2000 ·European Journal Of Haematology ·Börje Ridell, Jan Carneskog, Hans Wedel, Lars Vilén, Inge Høgh Dufva, Ulf‐Henrik Mellqvist, (unknown), Hans Wadenvik, Jack Kutti	20
5	Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group. 1996 ·PubMed ·Bengt Simonsson, Gunnar Öberg, Mats Björeman, Magnus Björkholm, Jan Carneskog, Goesta Gahrton, Robert Hast, (unknown), (unknown), Eva Löfvenberg, Christer Malm, Ingemar Turesson, (unknown), Lars Vilén, (unknown)	9
6	Intensive treatment in order to minimize the ph&hyphen;positive clone in chronic myelogenic leukemia 1993 ·Stem Cells ·Bengt Simonsson, Gunnar Öberg, A. Killander, (unknown), (unknown), Gösta Gahrton, Robert Hast, Ingemar Turesson, (unknown), Claes Malm, Lars Vilén, Anders Wåhlin, Eva Löfvenberg, Jan Carneskog, Jan Westin	15
7	Intensive Treatment in order to Minimize the Ph-Positive Clone in Chronic Myelogenic Leukemia 1992 ·Leukemia & lymphoma ·Bengt Simonsson, Gunnar Öberg, (unknown), (unknown), Gösta Gahrton, Robert Hast, A. Killander, Ingemar Turesson, (unknown), Olle Vikrot, Lars Vilén, Anders Wåhlin, Jan Carneskog, (unknown)	15
8	The effect of alpha-interferon on bone marrow megakaryocytes and platelet production rate in essential thrombocythemia 1991 ·Blood ·Hans Wadenvik, (unknown), (unknown), (unknown), (unknown), Bengt Magnusson, Jan Westin, Lars Vilén	37
9	ADP-Induced Platelet Aggregation as a Function of Age in Healthy Humans 1989 ·Thrombosis and Haemostasis ·Lars Vilén, S. O. Jacobsson, Hans Wadenvik, Jack Kutti	17
10	The Relation Between Platelet Reactivity and Coronary Angiographic Findings in Young Female Survivors of Acute Myocardial Infarction 1986 ·Thrombosis and Haemostasis ·Jack Kutti, Hans Wadenvik, Saga Johansson, Lars Vilén, A Vedin, Claes Wilhelmsson	1
11	Beta‐blockers as Anti‐platelet Drugs 1985 ·Acta Medica Scandinavica ·Jack Kutti, Lars Vilén	11
12	ADP‐induced Platelet Aggregation in Young Female Survivors of Acute Myocardial Infarction and Their Female Controls 1985 ·Acta Medica Scandinavica ·Lars Vilén, Saga Johansson, Jack Kutti, S Cronberg, A Vedin, Claes Wilhelmsson	13
13	ADP‐induced Platelet Aggregation and Metoprolol Treatment of Myocardial Infarction Patients 1985 ·Acta Medica Scandinavica ·Lars Vilén, Jack Kutti, Karl Swedberg, A Vedin	8
14	The Peripheral Platelet Count and ADP‐Induced Platelet Aggregation in Response to Metoprolol and Propranolol as Studied in Young Healthy Male Volunteers 1983 ·Scandinavian Journal of Haematology ·Lars Vilén, Jack Kutti, (unknown), Per Lundborg, S Cronberg	12
15	Presence of a Non‐Splenic Platelet Pool in Man 1980 ·Scandinavian Journal of Haematology ·Lars Vilén, (unknown), Jack Kutti	9
16	The Peripheral Platelet Count and the Isoprenaline‐Induced Splenic Platelet Pooling in Response to Beta‐Adrenoceptor Blockade 1979 ·Scandinavian Journal of Haematology ·(unknown), Lars Vilén, Per Lundborg, (unknown), Jack Kutti	3
17	Peripheral Platelet Count in Response to Salbutamol Before and After Adrenergic Beta-Receptor Blockade 1978 ·Acta Haematologica ·(unknown), (unknown), Lars Vilén, Jack Kutti	6
18	The Peripheral Platelet Count in Response to Adrenergic Alpha‐ and Beta‐1‐Receptor Stimulation 1978 ·Scandinavian Journal of Haematology ·(unknown), Per Lundborg, Lars Vilén, Jack Kutti	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact